Charite University, Berlin, Germany: Depressive Disorder, Major trials
The registry lists 12 Depressive Disorder, Major studies with Charite University, Berlin, Germany as lead sponsor. 1 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 1No phase 9(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Dopamine Modulation of Motivation and Motor Function in Major Depression & InflammationRecruitingNCT05909267Not applicable
- Simvastatin add-on Treatment to Standard Antidepressant Therapy in Patients With Comorbid Obesity and Major DepressionCompletedNCT04301271Phase 2
- Mineralocorticoid Receptor, NMDA Receptor and Cognitive Function in DepressionCompletedNCT03062150Not applicable
- Multimodal Imaging of ECT EffectsCompletedNCT02871141
- Depression and Immune Function in Multiple Sclerosis (MS)CompletedNCT02740296
- Psychotherapy Plus: Combining Cognitive Behavioral Therapy With tDCSCompletedNCT02633449Not applicable
- Noradrenergic Activity, Cognition and Major Depressive DisorderCompletedNCT02470026Not applicable
- Adjunct Minocyline in Treatment-resistant DepressionCompletedNCT02456948Phase 2
- HPA Axis Activity Due To Early Traumatic Stress and Metabolic SymptomsCompletedNCT02398877Not applicable
- Functional and Metabolic Changes in the Course of Antidepressive TreatmentCompletedNCT02099630
- Optimal Duration of Olanzapine Add-on Therapy in Major DepressionWithdrawnNCT00568672Phase 3
- Investigation of a Combination Treatment of Escitalopram and rTMSCompletedNCT00232700Not applicable